NO170834C - PROCEDURE FOR THE PREPARATION OF AN OSMOSE DEVICE FOR THE DELIVERY OF A USEFUL MEDICINE - Google Patents

PROCEDURE FOR THE PREPARATION OF AN OSMOSE DEVICE FOR THE DELIVERY OF A USEFUL MEDICINE

Info

Publication number
NO170834C
NO170834C NO840248A NO840248A NO170834C NO 170834 C NO170834 C NO 170834C NO 840248 A NO840248 A NO 840248A NO 840248 A NO840248 A NO 840248A NO 170834 C NO170834 C NO 170834C
Authority
NO
Norway
Prior art keywords
delivery
procedure
preparation
useful medicine
osmose device
Prior art date
Application number
NO840248A
Other languages
Norwegian (no)
Other versions
NO840248L (en
NO170834B (en
Inventor
Patrick S L Wong
Brian Barclay
Joseph C Deters
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO170834(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO840248L publication Critical patent/NO840248L/en
Publication of NO170834B publication Critical patent/NO170834B/en
Publication of NO170834C publication Critical patent/NO170834C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO840248A 1983-05-11 1984-01-24 PROCEDURE FOR THE PREPARATION OF AN OSMOSE DEVICE FOR THE DELIVERY OF A USEFUL MEDICINE NO170834C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (3)

Publication Number Publication Date
NO840248L NO840248L (en) 1984-11-12
NO170834B NO170834B (en) 1992-09-07
NO170834C true NO170834C (en) 1992-12-16

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840248A NO170834C (en) 1983-05-11 1984-01-24 PROCEDURE FOR THE PREPARATION OF AN OSMOSE DEVICE FOR THE DELIVERY OF A USEFUL MEDICINE

Country Status (20)

Country Link
JP (1) JPS6041609A (en)
AT (1) AT397180B (en)
AU (1) AU566110B2 (en)
BE (1) BE898819A (en)
CA (1) CA1222950A (en)
CH (1) CH669329A5 (en)
DE (1) DE3417113A1 (en)
DK (1) DK163910C (en)
ES (1) ES532018A0 (en)
FR (1) FR2545721B1 (en)
GB (1) GB2140687B (en)
IE (1) IE56515B1 (en)
IL (1) IL71727A (en)
IT (1) IT1178911B (en)
MX (1) MX163518B (en)
NL (1) NL192250C (en)
NO (1) NO170834C (en)
NZ (1) NZ206600A (en)
SE (1) SE455918B (en)
ZA (1) ZA842422B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (en) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド Pharmaceutical composition allowing the release of the active ingredient in a controlled manner
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
ES8800043A1 (en) * 1985-08-16 1987-10-16 Alza Corp Osmotic dispenser
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
DE3871343D1 (en) * 1987-11-25 1992-06-25 American Cyanamid Co SYSTEM FOR THE DELAYED (CONTROLLED) RELEASE OF SUBSTITUTED DIHYDROPYRIDINE CALCIUMANTAGONISTS.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
ATE106015T1 (en) * 1990-09-28 1994-06-15 Pfizer METER DELIVERY DEVICE CONTAINING A HYDROPHOBIC AGENT.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ES2158871T3 (en) * 1993-02-23 2001-09-16 Wolfgang Dr Werner USE OF A CALCIUM FORMULATION IN A MEDICINAL PRODUCT FOR THERAPEUTIC APPLICATION TO DAIRY COWS SUFFERING HYPOCALCEMIA.
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
CN101317825A (en) * 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
UA85850C2 (en) * 2003-09-19 2009-03-10 Сан Фарма Адвансед Ресьорч Компані Лтд. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (en) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmaceutical dosage forms containing a combination of nifedipine and / or nisoldipine and an angiotensin II antagonist
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
DE502006009169D1 (en) 2005-10-04 2011-05-05 Bayer Schering Pharma Ag NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
BRPI0925100A2 (en) * 2009-06-02 2016-07-19 Dow Global Technologies Llc osmotic dosage form and process for preparing an osmotic dosage form
DE102011007272A1 (en) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Branched 3-phenylpropionic acid derivatives and their use
MX2014013320A (en) 2012-05-07 2015-08-10 Bayer Pharma AG Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil.
UY34856A (en) 2012-07-03 2013-12-31 Bayer Pharma AG PHARMACEUTICAL PRESENTATION FORMS CONTAINING 5-CHLORO-N - ({(5S) -2-OXO-3- [4- (3-OXO-4- MORPHOLINYL) -PHENYL] -1,3-OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE
JP5941117B2 (en) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー Sustained release formulation
MA53368A (en) 2018-07-24 2021-06-02 Bayer Ag MODIFIED-RELEASE DOSAGE FORMS FOR ORAL ADMINISTRATION
CA3107174A1 (en) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (en) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
SE8402512L (en) 1984-11-12
NL192250C (en) 1997-04-03
NL192250B (en) 1996-12-02
IE56515B1 (en) 1991-08-28
ATA88084A (en) 1993-07-15
DK99784D0 (en) 1984-02-24
DE3417113C2 (en) 1989-02-02
DK163910C (en) 1992-09-14
IE840010L (en) 1984-11-11
SE455918B (en) 1988-08-22
IT1178911B (en) 1987-09-16
JPS6041609A (en) 1985-03-05
BE898819A (en) 1984-05-30
AU566110B2 (en) 1987-10-08
NO840248L (en) 1984-11-12
MX163518B (en) 1992-05-25
FR2545721B1 (en) 1987-11-06
GB2140687B (en) 1987-03-18
NZ206600A (en) 1987-01-23
IT8467283A1 (en) 1985-09-23
JPH0575725B2 (en) 1993-10-21
DK99784A (en) 1984-11-12
ES8503503A1 (en) 1985-03-01
IT8467283A0 (en) 1984-03-23
SE8402512D0 (en) 1984-05-09
DK163910B (en) 1992-04-21
NO170834B (en) 1992-09-07
ZA842422B (en) 1984-11-28
GB8334189D0 (en) 1984-02-01
CA1222950A (en) 1987-06-16
AT397180B (en) 1994-02-25
CH669329A5 (en) 1989-03-15
FR2545721A1 (en) 1984-11-16
GB2140687A (en) 1984-12-05
IL71727A (en) 1989-01-31
DE3417113A1 (en) 1984-11-15
ES532018A0 (en) 1985-03-01
NL8401470A (en) 1984-12-03
IL71727A0 (en) 1984-09-30
AU2251183A (en) 1984-11-15

Similar Documents

Publication Publication Date Title
NO170834C (en) PROCEDURE FOR THE PREPARATION OF AN OSMOSE DEVICE FOR THE DELIVERY OF A USEFUL MEDICINE
DK156376C (en) USE OF IBOGAIN FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF DRUGS
NO170667C (en) PROCEDURE FOR THE PREPARATION OF AN OSMOSE DEVICE Rendering of a useful agent
DK464383D0 (en) MEDICINE ADMINISTRATION APPARATUS
IT1169806B (en) DEVICE FOR THE CONTROLLED ADMINISTRATION OF DRUGS
NO863670L (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION OF A HYDROPHOBIC MEDICINE.
NO840709L (en) DELIVERY DEVICE FOR PASFORMED PRODUCTS
NO822556L (en) PROCEDURE FOR THE PREPARATION OF INHALATION MEDICINES
IT8267184A0 (en) BANDAGE FOR THE ADMINISTRATION OF MEDICINES
DK163959C (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING CIMETIDIN
NO875022D0 (en) DEVICE FOR MEDICAL DIAGNOSTIZATION.
NO168745C (en) PROCEDURE FOR PREPARING PHARMACEUTICAL MIXTURES
NO170792C (en) DEVICE FOR BREATHING OF FLUID
ZA81706B (en) Device for the administration of medicaments
NO810133L (en) PROCEDURE FOR THE PREPARATION OF A LIQUID.
FI824098L (en) THERAPEUTIC MEDICINE
NO865028L (en) PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC SYSTEM.
DK473088A (en) USE OF 2-AMINO-6-TRIFLUORMETHOXYBENZOTHIAZOL FOR THE PREPARATION OF A MEDICINE
DK473288D0 (en) USE OF 2-AMINO-6-TRIFLUORMETHOXYBENZOTHIAZOL FOR THE PREPARATION OF A MEDICINE
DK313281A (en) DEVICE FOR THE ADMINISTRATION OF MEDICAL ACTIVE SUBSTANCES
NO159101C (en) PROCEDURE FOR THE PREPARATION OF A BURN TREATMENT LIQUID
DK155682A (en) PROCEDURE FOR THE PREPARATION OF A PSYCHOTROTOPIC MEDICINE
DK164771C (en) PROCEDURE FOR THE PREPARATION OF A NATIONAL PHARMACEUTICAL PREPARATION CONTAINING ERGOT-CYCLIC PEPTIDAL KALOIDS
DE3483347D1 (en) INTRAVENOESE MEDICINE ADMINISTRATION DEVICE.
FI820999L (en) PROCEDURE FOR THE FRAMEWORK OF THE PHARMACEUTICAL SYSTEM

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN